Crinetics Pharmaceuticals, Inc. ($CRNX)
Filing Information
| Accession Number | 0001628280-26-044714 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 22, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
15,655
Total Value
$0.00
P&L
+inf% (+$1,307,662.15)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 18, 2026 | Grant/Award | 5,925 | $0.00 | $0.00 | 22,225 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 18, 2026 | Grant/Award | 9,730 | $0.00 | $0.00 | 9,730 | Direct | โ | View Details |